W. Pignat

763 total citations
23 papers, 663 citations indexed

About

W. Pignat is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, W. Pignat has authored 23 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in W. Pignat's work include Protein Kinase Regulation and GTPase Signaling (8 papers), Nitric Oxide and Endothelin Effects (4 papers) and Biomedical Research and Pathophysiology (3 papers). W. Pignat is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (8 papers), Nitric Oxide and Endothelin Effects (4 papers) and Biomedical Research and Pathophysiology (3 papers). W. Pignat collaborates with scholars based in Switzerland, Germany and United States. W. Pignat's co-authors include F. Märki, Klaus Vosbeck, Josef Pfeilschifter, Josef Pfeilschifter, Irmgard Wiesenberg, H. van den Bosch, Cynthia Alander, Lawrence G. Raisz, Bernard A. Roos and Jan A. Fischer and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

W. Pignat

23 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Pignat Switzerland 13 352 119 117 104 89 23 663
J H Gronich United States 7 490 1.4× 144 1.2× 67 0.6× 45 0.4× 41 0.5× 7 723
Rivka Hadar Israel 17 312 0.9× 92 0.8× 108 0.9× 55 0.5× 126 1.4× 37 841
Nelly Blaes France 14 254 0.7× 94 0.8× 130 1.1× 76 0.7× 51 0.6× 40 724
C P Sung United States 8 288 0.8× 159 1.3× 151 1.3× 77 0.7× 41 0.5× 11 775
Tsugumichi Saito Japan 18 568 1.6× 162 1.4× 119 1.0× 155 1.5× 62 0.7× 69 1.1k
Julie Lavie France 12 514 1.5× 101 0.8× 72 0.6× 61 0.6× 68 0.8× 18 796
H. G. Alpermann Germany 7 291 0.8× 180 1.5× 150 1.3× 193 1.9× 33 0.4× 11 892
Mildred Lam United States 9 507 1.4× 43 0.4× 103 0.9× 92 0.9× 55 0.6× 12 772
Heigoro Shirai United States 12 526 1.5× 91 0.8× 81 0.7× 114 1.1× 37 0.4× 14 896
Miyuki Nagasaki Japan 7 301 0.9× 74 0.6× 225 1.9× 60 0.6× 76 0.9× 7 779

Countries citing papers authored by W. Pignat

Since Specialization
Citations

This map shows the geographic impact of W. Pignat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Pignat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Pignat more than expected).

Fields of papers citing papers by W. Pignat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Pignat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Pignat. The network helps show where W. Pignat may publish in the future.

Co-authorship network of co-authors of W. Pignat

This figure shows the co-authorship network connecting the top 25 collaborators of W. Pignat. A scholar is included among the top collaborators of W. Pignat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Pignat. W. Pignat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiesenberg, Irmgard, Michele Chiesi, Martin Missbach, et al.. (1998). Specific Activation of the Nuclear Receptors PPARγ and RORA by the Antidiabetic Thiazolidinedione BRL 49653 and the Antiarthritic Thiazolidinedione Derivative CGP 52608. Molecular Pharmacology. 53(6). 1131–1138. 12 indexed citations
2.
Walker, Gaby, Dieter Kunz, W. Pignat, & Josef Pfeilschifter. (1998). Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1β- and cAMP-induced group II phospholipase A2 expression in rat renal mesangial cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1391(2). 213–222. 5 indexed citations
3.
Wiesenberg, Irmgard, Michele Chiesi, Martin Missbach, et al.. (1998). Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.. PubMed. 53(6). 1131–8. 43 indexed citations
4.
Walker, Gaby, Dieter Kunz, W. Pignat, H. van den Bosch, & Josef Pfeilschifter. (1997). Suppression by cyclosporin A of interleukin 1β‐induced expression of group II phospholipase A2 in rat renal mesangial cells. British Journal of Pharmacology. 121(4). 787–793. 22 indexed citations
5.
Walker, Gaby, Dieter Kunz, W. Pignat, et al.. (1996). Tetranactin inhibits interleukin 1β and cAMP induction of group II phospholipase A2 in rat renal mesangial cells. European Journal of Pharmacology. 306(1-3). 265–270. 11 indexed citations
6.
Walker, Gaby, Dieter Kunz, W. Pignat, H. van den Bosch, & Josef Pfeilschifter. (1995). Pyrrolidine dithiocarbamate differentially affects cytokine‐ and cAMP‐induced expression of group II phospholipase A2 in rat renal mesangial cells. FEBS Letters. 364(2). 218–222. 28 indexed citations
7.
Towbin, Harry, W. Pignat, & Irmgard Wiesenberg. (1995). Time-dependent cytokine production in the croton oil-induced mouse ear oedema and inhibition by prednisolone. Inflammation Research. 44(S2). S160–S161. 16 indexed citations
8.
Geiger, Thomas, et al.. (1993). The influence of anti-rheumatic drugs on hepatic mRNA levels of acute-phase proteins in rats with adjuvant arthritis. Inflammation Research. 38(S2). C69–C72. 3 indexed citations
9.
Pfeilschifter, Josef, Heiko Mühl, W. Pignat, F. Märki, & H. van den Bosch. (1993). Cytokine regulation of Group II phospholipase A2 expression in glomerular mesangial cells. European Journal of Clinical Pharmacology. 44(S1). S7–S9. 24 indexed citations
10.
Geiger, Thomas, et al.. (1993). Changes in hepatic mRNA levels of acute phase proteins during rat adjuvant arthritis.. PubMed. 10(5). 467–73. 8 indexed citations
11.
Mühl, Heiko, Thomas Geiger, W. Pignat, et al.. (1992). Transforming growth factors type‐β and dexamethasone attenuate group II phospholipase A2 gene expression by interleukin‐1 and forskolin in rat mesangial cells. FEBS Letters. 301(2). 190–194. 36 indexed citations
12.
Mühl, Heiko, Thomas Geiger, W. Pignat, et al.. (1991). PDGF suppresses the activation of group II phospholipase A2gene expression by interleukin I and forskolin in mesangial cells. FEBS Letters. 291(2). 249–252. 35 indexed citations
13.
Pfeilschifter, Josef, et al.. (1990). cAMP potentiates interleukin 1- and tumor necrosis factor-stimulated phospholipase A2 secretion from rat renal mesangial cells. Fresenius Journal of Analytical Chemistry. 337(1). 139–140. 5 indexed citations
14.
Pignat, W., et al.. (1990). Anti-inflammatory effects of cyclosporin A (CsA) in carragheenan-induced pleurisy in rats. Inflammation Research. 29(1-2). 105–107. 8 indexed citations
15.
Pfeilschifter, Josef, W. Pignat, Klaus Vosbeck, & F. Märki. (1989). Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells. Biochemical and Biophysical Research Communications. 159(2). 385–394. 171 indexed citations
16.
Pfeilschifter, Josef, W. Pignat, F. Märki, & Irmgard Wiesenberg. (1989). Release of phospholipase A2 activity from rat vascular smooth muscle cells mediated by cAMP. European Journal of Biochemistry. 181(1). 237–242. 39 indexed citations
17.
Pfeilschifter, Josef, W. Pignat, Klaus Vosbeck, F. Märki, & Irmgard Wiesenberg. (1989). Susceptibility of interleukin 1- and tumour necrosis factor-induced prostaglandin E2 and phospholipase A2 release from rat renal mesangial cells to different drugs. Biochemical Society Transactions. 17(5). 916–917. 12 indexed citations
18.
Böttcher, I., et al.. (1988). β-Agonist-induced tachyphylaxis in mouse skin. Inflammation Research. 23(1-2). 86–88. 2 indexed citations
19.
Pignat, W., et al.. (1986). How specific is the arachidonic acid-induced mouse ear oedema for lipoxygenase (LO)- and cyclooxygenase (CO)-inhibitors?. Inflammation Research. 19(5-6). 368–370. 7 indexed citations
20.
Roos, Bernard A., Jan A. Fischer, W. Pignat, Cynthia Alander, & Lawrence G. Raisz. (1986). Evaluation of thein Vivoandin VitroCalcium Regulating Actions of Noncalcitonin Peptides Produced via Calcitonin Gene Expression*. Endocrinology. 118(1). 46–51. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J H Gronich Breakdown of academic impact, for papers by Rivka Hadar Breakdown of academic impact, for papers by Nelly Blaes Breakdown of academic impact, for papers by C P Sung Breakdown of academic impact, for papers by Tsugumichi Saito Breakdown of academic impact, for papers by Julie Lavie Breakdown of academic impact, for papers by H. G. Alpermann Breakdown of academic impact, for papers by Mildred Lam Breakdown of academic impact, for papers by Heigoro Shirai Breakdown of academic impact, for papers by Miyuki Nagasaki
Rankless by CCL
2026